Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide Dosing in Moderate Persistent Asthma
NCT00305461Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2006
- Primary completion
- Mar 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ciclesonide in asthma, sponsored by AstraZeneca. Started Feb 2006; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00305461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305461.